The $NOVN (-0.25%) CEO Vas
Narasimhan said in an interview with #wef2025 that the pharmaceutical industry is seeking to work constructively with the new Trump administration, despite disagreements with Secretary of Health and Human Services Robert F. Kennedy Jr.
"We face the challenge that the head of the U.S. Department of Health and Human Services has publicly made anti-science statements"
"Yet we must work with the government to achieve important policy changes for our industry while standing up for vaccines and scientific principles"
Narasimhan reported initial positive discussions with the government. There has even been agreement on parts of the "Make America Healthy Again" agenda.
"This is completely in line with the goals of a company like Novartis"
"This common denominator is a good starting point."
